Haemonetics Corp (HAE)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$50.00

Buy

$67.49

arrow-down$-0.12 (-0.21%)

Prices updated at 01 Apr 2026, 21:10 EDT

Prices minimum 15 mins delay

Prices in USD

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

S&P 500

0.72%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Nov 2026
Annual general meeting	Jul 2026
Annual report	May 2026
Final results	May 2026

	Previous date
Half yearly results	Nov 2025
Annual general meeting	Jul 2025
Annual report	May 2025
Final results	May 2025

Company reports

01 Apr 2023

Annual Report

27 Dec 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.